General Info

Organix performs contract research and development for organic and medicinal chemistry and biotechnology applications. The company s capabilities include custom synthesis of organic molecules; optimization of existing synthetic methods; structure activity relationship studies to discover new molecules and optimize lead compounds; joint projects to discover and synthesize new molecular entities designed for specific functions; and characterization of components of complex organic mixtures. Organix is licensed by the United States Drug Enforcement Agency and the Commonwealth of Massachusetts to conduct research and manufacturing processes of controlled substances in schedules one to four. Its staff of scientists has been published in numerous scientific journals. The company was founded in 1986 and is based in Woburn, Mass.